Up to half of people who should be screened for colorectal cancer do not get the routine procedure. A blood test to detect colorectal cancer being developed by Stanford doctors and materials scientists could help change that.
Baker Family Co-Director of Stanford ChEM-H, Carolyn Bertozzi, has been recognized with the 2019 Gustavus John Esselen Award for Chemistry in the Public Interest for her work in manipulating the complex sugar coating on cell surfaces.
Brain cells called microglia serve as the brain’s garbage crew, scarfing up bits of cellular debris. But their underperformance in aging brains contributes to neurodegeneration. Now, a possible workaround?
While tuberculosis testing is now routine, standard tests don’t work for kids, people with HIV/AIDS and others who struggle to cough anything up from their lungs. A Stanford team is developing a new test to fill the gap.
A team led by Carolyn Bertozzi, the Baker Family Co-Director of Stanford ChEM-H, developed a tool to help cut down and study mucins, stubborn structures on cell surfaces that help cancers evade detection.
On Dec. 14, 2014, after many months of not getting expected results, biochemist Jim Spudich got into bed, read a chunk of a novel, fell asleep and had a dream that would change the focus of his entire field in thinking about what causes a common and often lethal heart defect.
Stanford researchers have found a way to predict who will suffer heart problems from a common breast-cancer drug, as well as identified an FDA-approved medication that could mitigate those side effects.